Lyn­dra lays off 23% of work­ers, to out­source man­u­fac­tur­ing as it ap­proach­es piv­otal read­out next month

Lyn­dra Ther­a­peu­tics is let­ting go about 23% of its work­force as the Boston-area biotech seeks to trim op­er­a­tional costs ahead of a piv­otal tri­al read­out …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.